Captor Therapeutics Spolka Akcyjna (CTX.WA)

PLN 32.2

(1.58%)

Operating Income Summary of Captor Therapeutics Spolka Akcyjna

  • Captor Therapeutics Spolka Akcyjna's latest annual operating income in 2023 was -73.01 Million PLN , down -108.84% from previous year.
  • Captor Therapeutics Spolka Akcyjna's latest quarterly operating income in 2024 Q1 was -9.72 Million PLN , up 41.57% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported an annual operating income of -38.36 Million PLN in 2022, down -20.99% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported an annual operating income of -31.7 Million PLN in 2021, down -159.56% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported a quarterly operating income of -10.75 Million PLN for 2024 Q2, down -4.11% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported a quarterly operating income of -16.63 Million PLN for 2023 Q4, down -2.29% from previous quarter.

Annual Operating Income Chart of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Historical Annual Operating Income of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Year Operating Income Operating Income Growth
2023 -73.01 Million PLN -108.84%
2022 -38.36 Million PLN -20.99%
2021 -31.7 Million PLN -159.56%
2020 -12.21 Million PLN -55.52%
2019 -7.85 Million PLN -90.19%
2018 -4.13 Million PLN -3005.26%
2017 -133 Thousand PLN 0.0%

Peer Operating Income Comparison of Captor Therapeutics Spolka Akcyjna

Name Operating Income Operating Income Difference
Bioceltix S.A. -15.81 Million PLN -361.555%
BIOTON S.A. 15.29 Million PLN 577.385%
Mabion S.A. 55.06 Million PLN 232.609%
Molecure S.A. -22.1 Million PLN -230.334%
NanoGroup S.A. -7.9 Million PLN -824.03%
Pharmena S.A. 34.87 Million PLN 309.389%
Poltreg S.A. -16.86 Million PLN -333.021%
Pure Biologics Spólka Akcyjna -31.71 Million PLN -130.204%
Ryvu Therapeutics S.A. -100.94 Million PLN 27.67%
Synthaverse S.A. 8.64 Million PLN 944.408%
Urteste S.A. -6.44 Million PLN -1032.558%